Cargando…
Correction: Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013)
Autores principales: | An, Hye Jin, Lee, Bonggi, Kim, Dae Hyun, Lee, Eun Kyeong, Chung, Ki Wung, Park, Min Hi, Jeong, Hyoung Oh, Kim, Sung Min, Moon, Kyoung Mi, Kim, Ye Ra, Kim, Seong Jin, Yun, Hwi Young, Chun, Pusoon, Yu, Byung Pal, Moon, Hyung Ryong, Chung, Hae Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546538/ https://www.ncbi.nlm.nih.gov/pubmed/28693125 http://dx.doi.org/10.18632/oncotarget.18922 |
Ejemplares similares
-
Physiological characterization of a novel PPAR pan agonist, 2-(4-(5,6-methylenedioxybenzo[d]thiazol-2-yl)-2-methylphenoxy)-2-methylpropanoic acid (MHY2013)
por: An, Hye Jin, et al.
Publicado: (2017) -
Novel PPARα agonist MHY553 alleviates hepatic steatosis by increasing fatty acid oxidation and decreasing inflammation during aging
por: Kim, Seong Min, et al.
Publicado: (2017) -
The Novel PPAR α/γ Dual Agonist MHY 966 Modulates UVB–Induced Skin Inflammation by Inhibiting NF-κB Activity
por: Park, Min Hi, et al.
Publicado: (2013) -
Potent Anti-Diabetic Effects of MHY908, a Newly Synthesized PPAR α/γ Dual Agonist in db/db Mice
por: Park, Min Hi, et al.
Publicado: (2013) -
PPARα Agonist, MHY3200, Alleviates Renal Inflammation during Aging via Regulating ROS/Akt/FoxO1 Signaling
por: Kim, Min Jo, et al.
Publicado: (2021)